Scott Henry
Stock Analyst at Alliance Global Partners
(2.23)
# 1,395
Out of 4,479 analysts
46
Total ratings
40.82%
Success rate
-2.41%
Average return
Main Sectors:
24 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $1.15 | +139.13% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $5.24 | +62.21% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.13 | +253.98% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.67 | +798.20% | 1 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $1.08 | +1,011.11% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $4.86 | +54.32% | 1 | Sep 22, 2023 | |
| DCTH Delcath Systems | Maintains: Buy | $10 → $13 | $7.91 | +64.35% | 3 | Aug 16, 2023 | |
| VKTX Viking Therapeutics | Maintains: Buy | $19 → $24 | $51.54 | -53.43% | 2 | May 3, 2023 | |
| IONM Assure Holdings | Maintains: Buy | $60 → $12 | $0.33 | +3,512.28% | 2 | Apr 12, 2023 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $85 → $90 | $84.79 | +6.14% | 7 | Dec 23, 2022 | |
| CPRX Catalyst Pharmaceuticals | Downgrades: Neutral | $10 → $16 | $15.80 | -1.90% | 2 | Aug 24, 2022 | |
| INVO INVO Bioscience | Downgrades: Neutral | $40 | $0.77 | +5,121.93% | 2 | Apr 13, 2022 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $275 → $250 | $2.38 | +10,404.20% | 3 | Aug 13, 2021 | |
| LMAT LeMaitre Vascular | Maintains: Neutral | n/a | $81.19 | - | 1 | Aug 3, 2021 | |
| IRMD IRadimed | Maintains: Buy | n/a | $43.67 | - | 1 | Aug 2, 2021 | |
| IRIX IRIDEX | Maintains: Buy | n/a | $2.01 | - | 2 | Mar 3, 2021 | |
| SRTS Sensus Healthcare | Maintains: Buy | n/a | $4.93 | - | 1 | Feb 26, 2021 | |
| INM InMed Pharmaceuticals | Maintains: Buy | n/a | $0.25 | - | 1 | Feb 16, 2021 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $0.57 | - | 1 | Dec 4, 2020 | |
| MYO Myomo | Upgrades: Buy | n/a | $2.81 | - | 1 | Nov 11, 2020 | |
| TNXP Tonix Pharmaceuticals Holding | Upgrades: Buy | n/a | $0.74 | - | 4 | Apr 18, 2019 | |
| QBIO Q BioMed | Downgrades: Neutral | n/a | $0.00 | - | 1 | Nov 29, 2018 | |
| NBY NovaBay Pharmaceuticals | Downgrades: Neutral | n/a | $2.17 | - | 1 | Mar 26, 2018 | |
| TTNP Titan Pharmaceuticals | Downgrades: Neutral | n/a | $5.43 | - | 1 | Nov 10, 2017 |
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $1.15
Upside: +139.13%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $5.24
Upside: +62.21%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.13
Upside: +253.98%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.67
Upside: +798.20%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $1.08
Upside: +1,011.11%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $4.86
Upside: +54.32%
Delcath Systems
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $7.91
Upside: +64.35%
Viking Therapeutics
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $51.54
Upside: -53.43%
Assure Holdings
Apr 12, 2023
Maintains: Buy
Price Target: $60 → $12
Current: $0.33
Upside: +3,512.28%
Ligand Pharmaceuticals
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $84.79
Upside: +6.14%
Catalyst Pharmaceuticals
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $15.80
Upside: -1.90%
INVO Bioscience
Apr 13, 2022
Downgrades: Neutral
Price Target: $40
Current: $0.77
Upside: +5,121.93%
Vivos Therapeutics
Aug 13, 2021
Maintains: Buy
Price Target: $275 → $250
Current: $2.38
Upside: +10,404.20%
LeMaitre Vascular
Aug 3, 2021
Maintains: Neutral
Price Target: n/a
Current: $81.19
Upside: -
IRadimed
Aug 2, 2021
Maintains: Buy
Price Target: n/a
Current: $43.67
Upside: -
IRIDEX
Mar 3, 2021
Maintains: Buy
Price Target: n/a
Current: $2.01
Upside: -
Sensus Healthcare
Feb 26, 2021
Maintains: Buy
Price Target: n/a
Current: $4.93
Upside: -
InMed Pharmaceuticals
Feb 16, 2021
Maintains: Buy
Price Target: n/a
Current: $0.25
Upside: -
Bionano Genomics
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.57
Upside: -
Myomo
Nov 11, 2020
Upgrades: Buy
Price Target: n/a
Current: $2.81
Upside: -
Tonix Pharmaceuticals Holding
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $0.74
Upside: -
Q BioMed
Nov 29, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.00
Upside: -
NovaBay Pharmaceuticals
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.17
Upside: -
Titan Pharmaceuticals
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $5.43
Upside: -